{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T23:04:44Z","timestamp":1783897484754,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Clinical Translation Project of Anhui Province","award":["Grant No.202204295107020049)"],"award-info":[{"award-number":["Grant No.202204295107020049)"]}]},{"name":"the Natural Science Foundation of Anhui Province","award":["Grant No. 2208085MH216"],"award-info":[{"award-number":["Grant No. 2208085MH216"]}]},{"name":"the Major Natural Science and Technology Project of Bengbu Medical Uuniversity","award":["Grant No. 2020byfy004"],"award-info":[{"award-number":["Grant No. 2020byfy004"]}]},{"name":"The Scientific Research Program of Anhui Provincial Health Commission","award":["Grant No. AHWJ2023BAc10028"],"award-info":[{"award-number":["Grant No. AHWJ2023BAc10028"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-51805-3","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:55:16Z","timestamp":1778568916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The gut microbiota and metabolomics in the pathogenesis of type 2 diabetes mellitus combined with coronary atherosclerotic heart disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Linjuan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"51805_CR1","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/S0140-6736(22)01655-5","volume":"400","author":"E Ahmad","year":"2022","unstructured":"Ahmad, E., Lim, S., Lamptey, R., Webb, D. R. & Davies, M. J. Type 2 diabetes. Lancet 400, 1803\u20131820 (2022).","journal-title":"Lancet"},{"key":"51805_CR2","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","volume":"10","author":"GA Gregory","year":"2022","unstructured":"Gregory, G. A. et al. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: A modelling study. Lancet Diabetes Endocrinol. 10, 741\u2013760 (2022).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"51805_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S2213-8587(21)00349-1","volume":"10","author":"Collaborators G. B. D. D. M.","year":"2022","unstructured":"Collaborators G. B. D. D. M. Diabetes mortality and trends before 25 years of age: An analysis of the Global Burden of Disease Study 2019. Lancet Diabetes Endocrinol. 10, 177\u2013192 (2022).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"51805_CR4","doi-asserted-by":"publisher","first-page":"e529","DOI":"10.1016\/j.cgh.2020.12.034","volume":"20","author":"S Yuan","year":"2022","unstructured":"Yuan, S., Gill, D., Giovannucci, E. L. & Larsson, S. C. Obesity, type 2 diabetes, lifestyle factors, and risk of gallstone disease: A Mendelian randomization investigation. Clin. Gastroenterol. Hepatol. 20, e529\u2013e537 (2022).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"51805_CR5","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.2337\/dc22-S002","volume":"45","author":"American Diabetes Association Professional Practice C.","year":"2022","unstructured":"American Diabetes Association Professional Practice C. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care 45, S17\u2013S38 (2022).","journal-title":"Diabetes Care"},{"key":"51805_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1054934","volume":"13","author":"Y Iwamoto","year":"2022","unstructured":"Iwamoto, Y. et al. Correlation of Baba\u2019s diabetic neuropathy classification with various diabetes-related complications. Front Endocrinol (Lausanne) 13, 1054934 (2022).","journal-title":"Front Endocrinol (Lausanne)"},{"key":"51805_CR7","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1161\/CIRCRESAHA.121.319895","volume":"130","author":"AC O'Kelly","year":"2022","unstructured":"O\u2019Kelly, A. C. et al. Pregnancy and reproductive risk factors for cardiovascular disease in women. Circ. Res. 130, 652\u2013672 (2022).","journal-title":"Circ. Res."},{"key":"51805_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23168939","author":"H Meng","year":"2022","unstructured":"Meng, H. et al. New progress in early diagnosis of atherosclerosis. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms23168939 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"51805_CR9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41569-021-00647-9","volume":"19","author":"O Raitakari","year":"2022","unstructured":"Raitakari, O., Pahkala, K. & Magnussen, C. G. Prevention of atherosclerosis from childhood. Nat. Rev. Cardiol. 19, 543\u2013554 (2022).","journal-title":"Nat. Rev. Cardiol."},{"key":"51805_CR10","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","volume":"47","author":"E Falk","year":"2006","unstructured":"Falk, E. Pathogenesis of atherosclerosis. J. Am. Coll. Cardiol. 47, C7\u201312 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"51805_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051835","author":"A Poznyak","year":"2020","unstructured":"Poznyak, A. et al. The diabetes mellitus-atherosclerosis connection: The role of lipid and glucose metabolism and chronic inflammation. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21051835 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"51805_CR12","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.cmet.2021.07.001","volume":"33","author":"RH Eckel","year":"2021","unstructured":"Eckel, R. H., Bornfeldt, K. E. & Goldberg, I. J. Cardiovascular disease in diabetes, beyond glucose. Cell Metab. 33, 1519\u20131545 (2021).","journal-title":"Cell Metab."},{"key":"51805_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101557","volume":"64","author":"Y Cao","year":"2022","unstructured":"Cao, Y. et al. Role of gut microbe-derived metabolites in cardiometabolic diseases: Systems based approach. Mol. Metab. 64, 101557 (2022).","journal-title":"Mol. Metab."},{"key":"51805_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33824-6","volume":"13","author":"W Zhou","year":"2022","unstructured":"Zhou, W. et al. The gut microbe Bacteroides fragilis ameliorates renal fibrosis in mice. Nat. Commun. 13, 6081 (2022).","journal-title":"Nat. Commun."},{"key":"51805_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.931431","volume":"13","author":"J Zhu","year":"2022","unstructured":"Zhu, J. et al. The change of plasma metabolic profile and gut microbiome dysbiosis in patients with rheumatoid arthritis. Front. Microbiol. 13, 931431 (2022).","journal-title":"Front. Microbiol."},{"key":"51805_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12934-022-01973-4","volume":"21","author":"P Li","year":"2022","unstructured":"Li, P., Luo, H., Ji, B. & Nielsen, J. Machine learning for data integration in human gut microbiome. Microb. Cell Fact. 21, 241 (2022).","journal-title":"Microb. Cell Fact."},{"key":"51805_CR17","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/s41559-018-0519-1","volume":"2","author":"S Louca","year":"2018","unstructured":"Louca, S. et al. Function and functional redundancy in microbial systems. Nat. Ecol. Evol. 2, 936\u2013943 (2018).","journal-title":"Nat. Ecol. Evol."},{"key":"51805_CR18","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.21873\/invivo.11572","volume":"33","author":"A Patsouras","year":"2019","unstructured":"Patsouras, A. et al. Screening and risk assessment of coronary artery disease in patients with type 2 diabetes: An updated review. In Vivo 33, 1039\u20131049 (2019).","journal-title":"In Vivo"},{"key":"51805_CR19","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.numecd.2021.01.007","volume":"31","author":"R Tian","year":"2021","unstructured":"Tian, R. et al. Gut microbiota dysbiosis in stable coronary artery disease combined with type 2 diabetes mellitus influences cardiovascular prognosis. Nutr. Metab. Cardiovasc. Dis. 31, 1454\u20131466 (2021).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"51805_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jacc.2008.03.043","volume":"52","author":"GD Lewis","year":"2008","unstructured":"Lewis, G. D., Asnani, A. & Gerszten, R. E. Application of metabolomics to cardiovascular biomarker and pathway discovery. J. Am. Coll. Cardiol. 52, 117\u2013123 (2008).","journal-title":"J. Am. Coll. Cardiol."},{"key":"51805_CR21","doi-asserted-by":"publisher","first-page":"5398","DOI":"10.7150\/thno.41725","volume":"10","author":"IW Wu","year":"2020","unstructured":"Wu, I. W. et al. Integrative metagenomic and metabolomic analyses reveal severity-specific signatures of gut microbiota in chronic kidney disease. Theranostics 10, 5398\u20135411 (2020).","journal-title":"Theranostics"},{"key":"51805_CR22","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s40200-022-01068-2","volume":"21","author":"M Demirci","year":"2022","unstructured":"Demirci, M., Keskin, T. Z., Ozyazar, F. E., Kiraz, M. & Kocazeybek, N. Similar bacterial signatures in the gut microbiota of type 1 and type 2 diabetes patients and its association with G protein-coupled receptor 41 and 43 gene expression. J. Diabetes Metabolic Disorders. 21, 1359\u20131368 (2022).","journal-title":"J. Diabetes Metabolic Disorders"},{"key":"51805_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001319","author":"F Perraudeau","year":"2020","unstructured":"Perraudeau, F. et al. Improvements to postprandial glucose control in subjects with type 2 diabetes: A multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation. BMJ Open Diabetes Res. Care https:\/\/doi.org\/10.1136\/bmjdrc-2020-001319 (2020).","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"51805_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-021-02415-8","author":"PJ McMurdie","year":"2022","unstructured":"McMurdie, P. J. et al. Increased circulating butyrate and ursodeoxycholate during probiotic intervention in humans with type 2 diabetes. BMC Microbiol. https:\/\/doi.org\/10.1186\/s12866-021-02415-8 (2022).","journal-title":"BMC Microbiol."},{"key":"51805_CR25","doi-asserted-by":"publisher","first-page":"903570","DOI":"10.3389\/fcimb.2022.903570","volume":"12","author":"MM Rahman","year":"2022","unstructured":"Rahman, M. M., Or-Rashid, I. F., Mamun, M. H., Rahaman, A. A. & Islam, M. S. The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation. Front. Cell. Infect. Microbiol. 12, 903570 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"51805_CR26","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.tim.2022.08.003","volume":"31","author":"B Jia","year":"2023","unstructured":"Jia, B., Zou, Y., Han, X., Bae, J. W. & Jeon, C. O. Gut microbiome-mediated mechanisms for reducing cholesterol levels: Implications for ameliorating cardiovascular disease. Trends Microbiol 31, 76\u201391 (2023).","journal-title":"Trends Microbiol"},{"key":"51805_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/nu12102982","author":"BJH Verhaar","year":"2020","unstructured":"Verhaar, B. J. H., Prodan, A., Nieuwdorp, M. & Muller, M. Gut microbiota in hypertension and atherosclerosis: A review. Nutrients https:\/\/doi.org\/10.3390\/nu12102982 (2020).","journal-title":"Nutrients"},{"key":"51805_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02146","volume":"8","author":"M Lyu","year":"2017","unstructured":"Lyu, M. et al. Balancing herbal medicine and functional food for prevention and treatment of cardiometabolic diseases through modulating gut microbiota. Front Microbiol 8, 2146 (2017).","journal-title":"Front Microbiol"},{"key":"51805_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01107","volume":"8","author":"AZ Leite","year":"2017","unstructured":"Leite, A. Z. et al. Detection of increased plasma Interleukin-6 levels and prevalence of Prevotella copri and Bacteroides vulgatus in the feces of type 2 diabetes patients. Front Immunol 8, 1107 (2017).","journal-title":"Front Immunol"},{"key":"51805_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2014.00678","volume":"5","author":"AG Davis-Richardson","year":"2014","unstructured":"Davis-Richardson, A. G. et al. Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes. Front Microbiol 5, 678 (2014).","journal-title":"Front Microbiol"},{"key":"51805_CR31","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.51039","author":"A Akshay","year":"2023","unstructured":"Akshay, A., Gasim, R., Ali, T. E., Kumar, Y. S. & Hassan, A. Unlocking the gut-cardiac axis: A paradigm shift in cardiovascular health. Cureus https:\/\/doi.org\/10.7759\/cureus.51039 (2023).","journal-title":"Cureus"},{"key":"51805_CR32","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.276305","author":"L Qi","year":"2013","unstructured":"Qi, L. et al. Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes. JAMA https:\/\/doi.org\/10.1001\/jama.2013.276305 (2013).","journal-title":"JAMA"},{"key":"51805_CR33","doi-asserted-by":"crossref","unstructured":"Ferk, F. et al. Gallic acid improves health\u2010associated biochemical parameters and prevents oxidative damage of DNA in type 2 diabetes patients: results of a placebo\u2010controlled pilot study. Mol Nutr Food Res 62 (2018).","DOI":"10.1002\/mnfr.201700482"},{"key":"51805_CR34","doi-asserted-by":"crossref","unstructured":"Chao, J. et al. Gallic Acid Ameliorated Impaired Lipid Homeostasis in a Mouse Model of High-Fat Diet\u2014and Streptozotocin-Induced NAFLD and Diabetes through Improvement of \u03b2-oxidation and Ketogenesis. Front. Pharmacol.\u00a011. (2021).","DOI":"10.3389\/fphar.2020.606759"},{"key":"51805_CR35","doi-asserted-by":"crossref","unstructured":"Hong, Y. et al. Gallic acid improves the metformin effects on diabetic kidney disease in mice. Ren. Fail. : 45. (2023).","DOI":"10.1080\/0886022X.2023.2183726"},{"key":"51805_CR36","doi-asserted-by":"crossref","unstructured":"Cheng, Y., Zhao, J., Tse, H. F., Le, X. C. & Rong, J. Plant Natural Products Calycosin and Gallic Acid Synergistically Attenuate Neutrophil Infiltration and Subsequent Injury in Isoproterenol-Induced Myocardial Infarction: A Possible Role for Leukotriene B4 12-Hydroxydehydrogenase? Oxidative Medicine and Cellular Longevity : 2015: 1\u201312. (2015).","DOI":"10.1155\/2015\/434052"},{"key":"51805_CR37","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1080\/02841850701280874","volume":"48","author":"G Sonmez","year":"2016","unstructured":"Sonmez, G. et al. Magnetic resonance imaging findings of adult-onset glutaric aciduria type I. Acta Radiologica 48, 557\u2013559 (2016).","journal-title":"Acta Radiologica"},{"key":"51805_CR38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/09553002.2023.2245461","volume":"100","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Altered bile acid metabolism in skin tissues in response to ionizing radiation: Deoxycholic acid (DCA) as a novel treatment for radiogenic skin injury. Int. J. Radiat. Biol. 100, 87\u201398 (2024).","journal-title":"Int. J. Radiat. Biol."},{"key":"51805_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.fsi.2024.109376","volume":"146","author":"X Zheng","year":"2024","unstructured":"Zheng, X. et al. Bile acid and short chain fatty acid metabolism of gut microbiota mediate high-fat diet induced intestinal barrier damage in Macrobrachium rosenbergii. Fish Shellfish Immunol. 146, 109376 (2024).","journal-title":"Fish Shellfish Immunol."},{"key":"51805_CR40","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1093\/eurheartj\/ehx518","volume":"39","author":"P Mirtschink","year":"2018","unstructured":"Mirtschink, P., Jang, C., Arany, Z. & Krek, W. Fructose metabolism, cardiometabolic risk, and the epidemic of coronary artery disease. Eur. Heart J. 39, 2497\u20132505 (2018).","journal-title":"Eur. Heart J."},{"key":"51805_CR41","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s12275-021-0454-8","volume":"59","author":"S-c Li","year":"2021","unstructured":"Li, S.-c et al. Comparative analysis of type 2 diabetes-associated gut microbiota between Han and Mongolian people. J. Microbiol. 59, 693\u2013701 (2021).","journal-title":"J. Microbiol."},{"key":"51805_CR42","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11306-021-01851-x","volume":"17","author":"H Zhang","year":"2021","unstructured":"Zhang, H. et al. Potential biomarkers identified in plasma of patients with gestational diabetes mellitus. Metabolomics 17, 99 (2021).","journal-title":"Metabolomics"},{"key":"51805_CR43","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1039\/D4FO05633G","volume":"16","author":"L Huang","year":"2025","unstructured":"Huang, L. et al. Amelioration of metabolic syndrome in high-fat diet-fed mice by total sesquiterpene lactones of chicory via modulation of intestinal microbiota and bile acid excretion. Food Funct. 16, 1830\u20131846 (2025).","journal-title":"Food Funct."},{"key":"51805_CR44","doi-asserted-by":"crossref","unstructured":"Sinha, T. et al. Navigating the gut-cardiac axis: understanding cardiovascular complications in inflammatory bowel disease. Cureus (2024).","DOI":"10.7759\/cureus.55268"},{"key":"51805_CR45","doi-asserted-by":"crossref","unstructured":"Hay\u0131ro\u011flu, M. \u0130., \u00c7\u0131nar, T., Palice, \u00c7. V., Ayhan, A. & Tekke\u015fin, G. A. \u0130. The Triglyceride-glucose index can predict long-term major adverse cardiovascular events in Turkish patients with high cardiovascular risk. J. Lipid Atherosclerosis : 11. (2022).","DOI":"10.12997\/jla.2022.11.3.280"},{"key":"51805_CR46","doi-asserted-by":"crossref","unstructured":"Hay\u0131ro\u011flu, M. \u0130. Clinical characteristics and outcomes of acute coronary syndrome patients with intra-aortic balloon pump in intensive cardiac care unit of a tertiary clinic. Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology (2017).","DOI":"10.5543\/tkda.2017.11126"},{"key":"51805_CR47","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.hlc.2017.10.023","volume":"28","author":"M\u0130 Hay\u0131ro\u011flu","year":"2019","unstructured":"Hay\u0131ro\u011flu, M. \u0130 et al. Predictors of in-hospital mortality in patients with ST-segment elevation myocardial infarction complicated with cardiogenic shock. Heart Lung Circ. 28, 237\u2013244 (2019).","journal-title":"Heart Lung Circ."},{"key":"51805_CR48","doi-asserted-by":"crossref","unstructured":"Li, M. et al. Correlations between gut microbiota and serum metabolomics in patients with neurogenic rosacea. BMC Microbiol. : 25. (2025).","DOI":"10.1186\/s12866-025-04173-3"},{"key":"51805_CR49","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.thromres.2024.01.022","volume":"235","author":"Z Fan","year":"2024","unstructured":"Fan, Z. et al. Disordered gut microbiota and alterations in the serum metabolome are associated with venous thromboembolism. Thromb. Res. 235, 68\u201374 (2024).","journal-title":"Thromb. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51805-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51805-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51805-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T22:27:16Z","timestamp":1783895236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51805-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51805"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51805-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"29 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in compliance with the principles of the Declaration of Helsinki (2013 revision). Ethical approval was obtained from the Medical Ethics Committee of Bengbu Medical University (Approval No. 2022KY096), and written informed consent was voluntarily provided by all participants prior to their enrollment in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethics Guidelines"}}],"article-number":"21657"}}